MONTVALE, N.J., Feb. 5 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. today announced that James Sulat, President and Chief Executive Officer, will provide a company update at the 10th Annual BIO CEO & Investor Conference on Tuesday, February 12, 2008 at 10:15 a.m. ET at The Waldorf=Astoria Hotel in New York City.
Interested parties may access the live webcast of the presentation by visiting the “Investors” section of Memory Pharmaceuticals’ website at http://www.memorypharma.com. Archived versions of the webcast will be available at the same location for one week following the presentation.
About the Company
Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on developing innovative drugs for the treatment of debilitating CNS disorders such as Alzheimer’s disease, schizophrenia, depression and bipolar disorder. For additional information, please visit our website at http://www.memorypharma.com.
CONTACT: Jzaneen Lalani, General Counsel for Memory Pharmaceuticals Corp.,
+1-201-802-7249; or Lillian Stern of Stern Investor Relations, Inc. for
Memory Pharmaceuticals Corp., +1-212-362-1200
Web site: http://www.memorypharma.com//
